All Journals All Articles | Search Log In
Articles Special Topics Volumes Webinars Videos
Articles Special Topics Volumes Webinars Interviews

Volume

King syndrome: what’s in a name?

Pharmacogenetics and pharmacogenomics in human diseases

Omics analyses provide insights to CART cell therapy resistance

Idiopathic generalized epilepsy and café-au-lait macules as the predominant features in NF1 mild form

The (epi)genomic landscape of splenic marginal zone lymphoma, biological implications, clinical utility, and future questions

Duo Shared Genomic Segment analysis identifies a genome-wide significant risk locus at 18q21.33 in myeloma pedigrees

Large-scale genomic data-mining implicates dysregulated nuclear receptor-mediated signaling in mental illness

Kava root extracts hinder prostate cancer development and tumorigenesis by involvement of dual inhibition of MAO-A and LSD1

An update of aberrant methylation detection on circulating cell-free DNA as a tool to improve prostate cancer diagnosis and prognosis

B-cell receptor stereotyped subsets and outcome for patients with chronic lymphocytic leukemia in the HOVON 68 trial

Shared genomic segment analysis in a large high-risk chronic lymphocytic leukemia pedigree implicates <i>CXCR4</i> in inherited risk

Genome-wide homozygosity and risk of four non-Hodgkin lymphoma subtypes

Actions for 0 selected articles

Journal of Translational Genetics and Genomics
ISSN 2578-5281 (Online)
Navigation
Follow Us
Navigation

Committee on Publication Ethics

https://members.publicationethics.org/members/journal-translational-genetics-and-genomics

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Committee on Publication Ethics

https://members.publicationethics.org/members/journal-translational-genetics-and-genomics

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/
Contact Us
Follow OAE
Twitter
Facebook
LinkedIn
YouTube
BiLiBiLi
WeChat
Rss
© 2016-2026 OAE Publishing Inc., except certain content provided by third parties